<unk>  (EDU/OHPH/TCHP), sold under the brand name Trioestrine Retard, is an injectable combination medication of estradiol<unk>  (EDU), an estrogen,<unk><unk>  (OHPH), a progestogen, and testosterone<unk>  (TCHP), an androgen/anabolic steroid. It contained 2.25 mg EDU, 100 mg OHPH, and 67.5 mg TCHP in oil solution, was provided as ampoules, and was administered by intramuscular injection. The medication was manufactured by Roussel and Théramex and was marketed by 1953. It is no longer available.
Estradiol diundecylate/hydroxyprogesterone heptanoate/testosterone cyclohexylpropionate
Estradiol benzoate/estradiol dienanthate/testosterone enanthate benzilic acid hydrazone
Estradiol benzoate/estradiol phenylpropionate/testosterone propionate/testosterone phenylpropionate/testosterone isocaproate
Testosterone propionate/testosterone enanthate/testosterone undecylenate
Testosterone acetate/testosterone undecanoate/testosterone valerate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate
Testosterone propionate/testosterone valerate/testosterone undecylenate
Estradiol benzoate butyrate/algestone acetophenide